In Pharmaceutical Industry today’s main concern is the identification and presence of nitrosamines in drug products and drug substances. The manufacturers of active pharmaceutical ingredients (APIs) and drug products have the findings of nitrosamine impurities which may be likely human carcinogens and require the need for risk assessment strategy for potential nitrosamines and their presence.
The US Food and Drug Administration (FDA) on 4th Aug 2023 released the final guidance document on the “Recommended Acceptable Intake Limits for Nitrosamine Drug substance-Related Impurities (NDSRIs guidance)”. This guidance recommends predicting the mutagenic and carcinogenic potential of nitrosamine drug substance-related impurities (NDSRIs) that might be present in drug products and recommends (AI) acceptable limits for NDSRIs to the manufacturers and applicants of drugs including prescription and over-the-counter (OTC) drug products.
NDSRIs are the class of nitrosamine impurities that have been identified in many active pharmaceutical ingredients (APIs) and in drug products. These impurities share structural similarity to the API (having API fragment or API in the chemical structure) and hence unique to each API. Through nitrosation of APIs (or API fragments) NDSRIs form in the drug product which have secondary or tertiary amines when exposed to nitrosating agents like residual nitrites in excipients which are used to formulate drug products.
This guidance suggests a risk-based safety assessment for NDSRIs to be used by the manufacturers and applicants to identify AI limits in their APIs and drug products in alliance with recommendations given in the guidance for industry control of Nitrosamine impurities in human drugs ( Feb 2021) Nitrosamine guidance.
The detection of nitrosamine impurities was found in some of the commonly prescribed medicines used for treating diabetes, antacids, and others. Nitrosamine impurities and their presence and investigation in some of the drug products have been carried out by the FDA since 2018 when the FDA was informed of the presence of an impurity as N-Nitrosodimethylamine (NDMA) in the angiotensin receptor blocker Valsartan.
In drug products, the initial reports of nitrosamine impurities were of small molecules of nitrosamines such as NDMA, compounds that are formed by nitrosating reactions between amines (secondary, tertiary, or quaternary amines) and nitrous acid (nitrite salts under acidic conditions) that are generally due to synthesis of API conditions that introduce nitrite, nitrous acid, and amide solvents.
FDA issued guidance to the industry in the year 2020, the Nitrosamine Guidance recommending that the manufacturers of drug products and API should take steps to detect and prevent unacceptable levels of nitrosamine impurities in drug products or to avoid their presence when feasible.
The Nitrosamine guidance introduced a three-step process that manufacturers and applicants should take to mitigate nitrosamine impurities in their drug products.
- Conduct risk assessments for nitrosamine impurities in their APIs and drug products.
- Conduct confirmatory testing if risk is identified and
- A reported change is implemented to reduce or prevent the presence of nitrosamine impurities in drug products and APIs in approved and pending NDAs and ANDAs.
FDA also recommends to the manufacturers and applicants whose drug products contain multiple nitrosamines: If more than one nitrosamine impurity (NDSRI(s) and /or small molecule nitrosamine(s) is identified and if the nitrosamine total level exceeds the recommended AI limit for most of the potent nitrosamine in the drug product based on the maximum daily dose the applicant or the manufacturer should contact the agency.
Recommended AI limits for NDSRIs at risk of formation in certain APIs: FDA has identified a number of APIs that have secondary or tertiary amines and so are at risk for forming NDSRIs. Hypothetically under certain conditions related to the manufacturing and formulation process for the drug product, such as residual nitrites in excipients used to formulate the drug product, these APIs could form NDSRIs.
FDA has applied the predicted carcinogenic potency categorization to these APIs. Furthermore correctly based on the scientific analysis of chemical structures they have concluded that when an API contains hypothetical nitrosated forms of secondary amine- and dimethyl tertiary amine- groups these recommended AI limits based on predicted carcinogenic potency should be applied to the NDSRIs to the extent they form in the these APIs.
Nitroso Impurities
CAS No. | Name of Impurity | Catalogue No. |
---|---|---|
N/A | ABCRC-1 Dinitroso Impurity | VE007759 |
N/A | ABCRC-1 Nitroso Impurity-1 | VE007757 |
N/A | ABCRC-1 Nitroso Impurity-2 | VE007758 |
N/A | Abacavir Nitroso-1 | VE007065 |
N/A | Acarbose Nitroso Impurity 1 | VE0011237 |
N/A | Avanafil Nitroso Impurity 1 | VE0014150 |
N/A | Bupropion Nitroso Impurity | VE009664 |
N/A | Carvedilol Di-Nitroso | VE0010478 |
N/A | Cilnidipine Nitroso Impurity | VE008671 |
N/A | Clevidipine Nitroso Impurity | VE0014062 |
7458-08-4 | Clomipramine EP Impurity E (Nitroso Impurity) | VE009769 |
78213-40-8 | Clomipramine EP Impurity F Nitroso Impurity | VE0010055 |
N/A | Darolutamide Nitroso Impurity | VE0010234 |
N/A | Dasatinib Nitroso Impurity | VE0011523 |
148950-50-9 | Di-Nitroso-Clonidine | VE0011406 |
13256-12-7 | Diethylamine Dinitroso Impurity | VE009666 |
23834-30-2 | Diethylamine Nitroso Impurity | VE009665 |
55556-94-0 | Dinitroso-Methyl piperazine Gatifloxacin | VE008163 |
N/A | Duloxetine Nitroso Impurity | VE007668 |
N/A | Elagolix Nitroso Impurity | VE009406 |
N/A | Elagolix ethyl ester nitroso impurity | VE009692 |
N/A | Eletriptan Nitroso Impurity | VE0010500 |
N/A | Ethyl 1-nitroso-1H-tetrazole-5-carboxylate | VE0012581 |
N/A | Ethyl 1-nitroso-4-oxo-1, 4-dihydroquinoline-3-carboxylate | VE0011351 |
N/A | Ezetimibe Nitroso Impurity | VE0010294 |
N/A | Ezetimibe Nitroso Impurity 1 | VE0010001 |
N/A | Ezetimibe Nitroso Impurity 2 | VE0010003 |
N/A | Fomepizole Nitroso Impurity | VE0014755 |
N/A | Frovatriptan Nitroso Impurity 1 | VE0010499 |
N/A | Frovatriptan Nitroso Impurity 2 | VE0010501 |
N/A | Granisetron Nitroso Impurity | VE0011607 |
1233340-45-8 | Imidazole Nitroso Impurity | VE007717 |
N/A | Indacaterol Nitroso Impurity | VE0010331 |
N/A | Irbesartan Nitroso Impurity 1 | VE006176 |
N/A | Irbesartan Nitroso Impurity 2 | VE008461 |
N/A | Irbesartan Nitroso Spiro Impurity | VE006185 |
N/A | Isopropyl (2-amino-6-((4-fluorobenzyl)(nitroso)amino)pyridin-3-yl)carbamate - Flupirtine | VE007901 |
N/A | Ivacaftor Nitroso Impurity | VE0010062 |
N/A | Lansoprazole Nitroso Impurity | VE007769 |
N/A | Levomefolate Nitroso Impurity 1 | VE0014190 |
N/A | Levomefolate Nitroso Impurity 2 | VE0014191 |
6972-78-7 | Linagliptin Nitroso Pyrimidine Impurity | VE007060 |
N/A | Lumateperone Nitroso Impurity 3 | VE009758 |
N/A | Methyl (2-amino-6-((4-fluorobenzyl)(nitroso)amino)pyridin-3-yl)carbamate - Flupirtine | VE007903 |
946126-94-9 | Methyl 2-fluoro-3-nitrobenzoate | VE0011046 |
68061-82-5 | Methyl N-Methyl-N-Nitrosoanthranilate | VE0012234 |
N/A | Metolazone Nitroso Impurity 1 | VE0011404 |
148950-49-6 | Mono-Nitroso Clonidine Impurity | VE0010228 |
N/A | Mononitroso Ethambutol ( S Isomer) | VE009913 |
N/A | Moxifloxacin Related Compound A Nitroso Impurity | VE0011337 |
N/A | Moxifloxacin Related Compound B Nitroso Impurity | VE0011338 |
N/A | Moxifloxacin Related Compound C Nitroso Impurity | VE0011339 |
N/A | Moxifloxacin Related Compound D Nitroso Impurity | VE0011340 |
N/A | Moxifloxacin Related Compound G Nitroso Impurity | VE0011341 |
N/A | Moxonidine Imine Nitroso Impurity | VE009855 |
N/A | N, N'-(5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine-3, 7-diyl)diacetamide | VE009785 |
N/A | N, N-DiNitroso Moxonidine Impurity | VE009854 |
53743-85-4 | N, N-Diethyl-4-nitrosoaniline HCl | VL6590009 |
N/A | N, N-dimethyl-2-(1-nitroso-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethanamine | VE0011198 |
13256-06-9 | N- Nitroso Diamyl Amine | VE006109 |
N/A | N-(1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)nitrous amide | VE009892 |
N/A | N-(2-((2-(dimethylamino)ethyl)(nitroso)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | VE009898 |
N/A | N-(2-(ethyl(nitroso)amino)ethyl)-2, 4-dimethyl-1H-pyrrole-3-carboxamide | VE0010010 |
N/A | N-(2-(ethyl(nitroso)amino)ethyl)-5-formyl-2, 4-dimethyl-1H-pyrrole-3-carboxamide | VE0010011 |
N/A | N-(2-aminopyridin-3-yl)-N-(1-nitrosopiperidin-4-yl)nitrous amide | VE0010249 |
N/A | N-(2-ethylphenyl)nitrous Hydrazide | VE0011263 |
N/A | N-(3-((3-(3-chloro-10, 11-dihydro-5H-dibenzo[b, f]azepin-5-yl)propyl)(methyl)amino)propyl)-N-methylnitrous amide | VE009804 |
N/A | N-(3-(10, 11-dihydro-5H-dibenzo[b, f]azepin-5-yl)propyl)-N-methylnitrous amide | VE009806 |
N/A | N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2-fluoro-6-methoxybenzenesulfonamide | VE0011061 |
N/A | N-(3-(3, 7-dichloro-10, 11-dihydro-5H-dibenzo[b, f]azepin-5-yl)propyl)-N-methylnitrous amide | VE009808 |
N/A | N-(3-(3-chloro-10, 11-dihydro-5H-dibenzo[b, f]azepin-5-yl)propyl)-N-(3-(dimethylamino)propyl)nitrous amide | VE009805 |
N/A | N-(3-(3-chloro-5H-dibenzo[b, f]azepin-5-yl)propyl)-N-methylnitrous amide | VE009807 |
N/A | N-(3-(dimethylamino)propyl)-N-methylnitrous amide | VE009810 |
N/A | N-(3-chloropropyl)-N-methylnitrous amide | VE009809 |
N/A | N-(4-ethyl-2-(methyl(2-(methyl(nitroso)amino)ethyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | VE009899 |
N/A | N-(5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepin-3-yl)acetamide | VE009784 |
123704-98-3 | N-Acetylaminoisonitrosoacetanilide | VE0014769 |
N/A | N-Dinitroso Almotriptan | VE0011196 |
N/A | N-Nitroso -2, 6 dichloro purine | VE006125 |
N/A | N-Nitroso 3-MPPP | VE007898 |
N/A | N-Nitroso AFBP Impurity (Flupirtine) | VE007888 |
N/A | N-Nitroso ANFP Impurity (Flupirtine) | VE007887 |
N/A | N-Nitroso Abacavir | VE0011534 |
N/A | N-Nitroso Abiraterone Acetate Nitrite | VE0011619 |
N/A | N-Nitroso Abiraterone Acetate Tetrafluoroborate | VE0011618 |
N/A | N-Nitroso Aceclofenac | VE0011687 |
N/A | N-Nitroso Allopurinol | VE0014231 |
N/A | N-Nitroso Alogliptin Benzoate Dimer Impurity | VE0012079 |
N/A | N-Nitroso Alogliptin Impurity 12 | VE0012078 |
N/A | N-Nitroso Altizide | VE008448 |
N/A | N-Nitroso Amlodipine EP Impurity B | VE0010278 |
N/A | N-Nitroso Amlodipine EP Impurity E | VE0010289 |
N/A | N-Nitroso Amlodipine EP Impurity F | VE0010288 |
N/A | N-Nitroso Amlodipine EP Impurity G | VE0010284 |
N/A | N-Nitroso Amlodipine EP Impurity H | VE0010286 |
N/A | N-Nitroso Amlodipine Galactose Adduct Impurity | VE0010287 |
N/A | N-Nitroso Amlodipine Impurity-1 | VE008552 |
N/A | N-Nitroso Amlodipine Lactose Adduct Impurity | VE0010285 |
N/A | N-Nitroso Amlodipine atorvastatine Adduct | VE0010279 |
N/A | N-Nitroso Apremilast | VE0011283 |
N/A | N-Nitroso Argatroban | VE0014149 |
N/A | N-Nitroso Atazanavir | VE0014358 |
N/A | N-Nitroso Atenolol Impurity G | VE0011712 |
N/A | N-Nitroso Atenolol Impurity H | VE0011713 |
N/A | N-Nitroso Atenolol Impurity I | VE0011714 |
N/A | N-Nitroso Azithromycin | VE0010108 |
N/A | N-Nitroso Azithromycin EP Impurity I | VE0010109 |
N/A | N-Nitroso Balofloxacin | VE0013088 |
N/A | N-Nitroso Benazepril | VE0011179 |
N/A | N-Nitroso Bendamustine | VE008451 |
N/A | N-Nitroso Bendroflumethazide | VE008450 |
N/A | N-Nitroso Betahistine EP Impurity C | VE0010864 |
N/A | N-Nitroso Binimetinib | VE0012757 |
N/A | N-Nitroso Brinzolamide | VE0014151 |
2490432-02-3 | N-Nitroso Bumetanide Impurity | VE006127 |
N/A | N-Nitroso Candesartan Cilexetil EP Impurity A | VE0010305 |
N/A | N-Nitroso Candesartan Cilexetil EP Impurity B | VE0010308 |
N/A | N-Nitroso Candesartan Cilexetil EP Impurity G | VE0010306 |
N/A | N-Nitroso Candesartan Cilexetil EP Impurity I | VE0010307 |
N/A | N-Nitroso Candesartan Cilexetil Impurity | VE0010328 |
N/A | N-Nitroso Cangrelor | VE0014154 |
N/A | N-Nitroso Carbidopa | VE0010461 |
2248746-67-8 | N-Nitroso Carvedilol | VE0010476 |
N/A | N-Nitroso Caspofungin | VE0014156 |
N/A | N-Nitroso Celiprolol | VE0010031 |
2005-04-1 | N-Nitroso Cetirizine EP Impurity A | VE0013096 |
N/A | N-Nitroso Chloroquine | VE0011720 |
N/A | N-Nitroso Cinacalcet | VE007661 |
N/A | N-Nitroso Citrate De Betaine | VE0011305 |
N/A | N-Nitroso Clonidine Impurity | VE0011405 |
156632-03-0 | N-Nitroso Clozapine | VE0013883 |
N/A | N-Nitroso Clozapine EP Impurity C | VE0013882 |
N/A | N-Nitroso Dabigatran Impurity 14 | VE0014038 |
N/A | N-Nitroso Dabigatran Impurity 33 | VE0014039 |
N/A | N-Nitroso Dabigatran Impurity 65 | VE0014040 |
N/A | N-Nitroso Dabigatran Impurity 73 (TFA Salt) | VE0014041 |
N/A | N-Nitroso Dabigatran Impurity 8 | VE0014043 |
N/A | N-Nitroso Dabigatran Impurity 83 | VE0014037 |
N/A | N-Nitroso Daclatasvir | VE0014364 |
N/A | N-Nitroso Dapsone | VE0011247 |
57164-17-7 | N-Nitroso Desipramine | VE0014166 |
1246819-22-6 | N-Nitroso Desloratadine | VE007389 |
N/A | N-Nitroso Desmethyl Almotriptan Impurity | VE0011197 |
N/A | N-Nitroso Desmethyl Azelastine | VE0010362 |
N/A | N-Nitroso Desmethyl Cabergoline | VE0014152 |
N/A | N-Nitroso Desmethyl Chlorpheniramine | VE0014158 |
55855-44-2 | N-Nitroso Desmethyl Chlorpromazine | VE0014159 |
N/A | N-Nitroso Desmethyl Clarithromycin | VE0014163 |
N/A | N-Nitroso Desmethyl Clomipramine | VE009800 |
N/A | N-Nitroso Desmethyl Cyclobenzaprine | VE0014165 |
N/A | N-Nitroso Desmethyl Eletriptan Impurity | VE0010502 |
N/A | N-Nitroso Desmethyl N-Nitroso Sumatriptan Impurity | VE0011262 |
N/A | N-Nitroso Desmethyl Sumatriptan Impurity | VE0010179 |
N/A | N-Nitroso Desmethyl Tamoxifen | VE0014157 |
N/A | N-Nitroso Desmethyl Tapentadol | VE0014155 |
N/A | N-Nitroso Dextromethorphan EP Impurity A | VE0010481 |
66505-80-4 | N-Nitroso Diclofenac | VE009623 |
55-18-5 | N-Nitroso Diethylamine (NDEA) | VL3850024 |
55855-43-1 | N-Nitroso Diphenhydramine | VE0011180 |
63819-70-5 | N-Nitroso Diterbutylamine | VE007730 |
N/A | N-Nitroso Dolutegravir | VE0014359 |
N/A | N-Nitroso Domperidone | VE0011581 |
N/A | N-Nitroso Dorzolamide | VE0010215 |
N/A | N-Nitroso Dorzolamide-D5 | DVE00534 |
N/A | N-Nitroso Doxepin EP Impurity C | VE0014568 |
N/A | N-Nitroso Edoxaban Impurity 70 | VE0013032 |
N/A | N-Nitroso Eltrombopag | VE0010123 |
N/A | N-Nitroso Enalapril | VE0010474 |
1850-61-9 | N-Nitroso Ephedrine | VE0011708 |
N/A | N-Nitroso Epinephrine | VE0014063 |
N/A | N-Nitroso Ertapenem | VE0014172 |
N/A | N-Nitroso Escitalopram Impurity | VE006453 |
N/A | N-Nitroso Esmolol | VE0014170 |
N/A | N-Nitroso Etravirine | VE0014171 |
N/A | N-Nitroso Famotidine 1 | VE0011719 |
N/A | N-Nitroso Fenoldopam Impurity | VE008184 |
N/A | N-Nitroso Finasteride Impurity 1 | VE0013942 |
N/A | N-Nitroso Finasteride Impurity 2 | VE0013943 |
N/A | N-Nitroso Finerenone | VE0014374 |
N/A | N-Nitroso Fingolimod | VE0011248 |
N/A | N-Nitroso Flecainide | VE0014173 |
150494-06-7 | N-Nitroso Fluoxetine | VE007630 |
N/A | N-Nitroso Flupirtine | VE006870 |
N/A | N-Nitroso Flupirtine Related Compound 9 | VE0010473 |
N/A | N-Nitroso Folic Acid Impurity-II | VE008186 |
N/A | N-Nitroso Fostamatinib-1 | VE0014353 |
N/A | N-Nitroso Fostamatinib-2 | VE0014355 |
N/A | N-Nitroso Gentamicin 1 | VE007829 |
N/A | N-Nitroso Gentamicin 2 | VE007831 |
N/A | N-Nitroso Gentamicin 3 | VE007832 |
N/A | N-Nitroso Hydralazine | VE0014352 |
N/A | N-Nitroso Hydrochlorothiazide | VE009704 |
N/A | N-Nitroso Imatinib | VE0013972 |
N/A | N-Nitroso Imidazole Ester Olmesartan | VE007890 |
38652-29-8 | N-Nitroso Iminostilbene | VE009768 |
N/A | N-Nitroso Impurity A1 | VE0011510 |
N/A | N-Nitroso Impurity A2 | VE0011511 |
N/A | N-Nitroso Impurity A3 | VE0011512 |
N/A | N-Nitroso Impurity B | VE0011513 |
N/A | N-Nitroso Isoxsuprine | VE0014183 |
N/A | N-Nitroso Isradipine | VE0014184 |
2820170-74-7 | N-Nitroso Labetalol | VE007835 |
N/A | N-Nitroso Labetolol | VE007835 |
N/A | N-Nitroso Lercanidipine | VE0011168 |
N/A | N-Nitroso Levalbuterol | VE0014185 |
N/A | N-Nitroso Levetiracetam Impurity | VE0014273 |
N/A | N-Nitroso Levobunolol | VE0014186 |
14340-33-1 | N-Nitroso Levodropropizine EP Impurity B | VE0014579 |
2089332-99-8 | N-Nitroso Levodropropizine EP Impurity B-D4 | DVE00549 |
N/A | N-Nitroso Lincomycin Impurity 1 | VE0011697 |
519175-80-5 | N-Nitroso Lisinopril | VE0010130 |
N/A | N-Nitroso Lisinopril EP Impurity E | VE0011216 |
N/A | N-Nitroso Lisinopril EP Impurity F | VE0011217 |
2518136-84-8 | N-Nitroso Lorcaserin | VE0014162 |
N/A | N-Nitroso Lumateperone | VE009759 |
N/A | N-Nitroso Maraviroc | VE0014362 |
N/A | N-Nitroso Mefloquine | VE0014192 |
278783-22-5 | N-Nitroso Melatonin | VE0011336 |
1219794-54-3 | N-Nitroso Melphalan EP Impurity K-D10 | DVE00133 |
N/A | N-Nitroso Meropenem | VE0014193 |
73829-38-6 | N-Nitroso Metamizole EP Impurity C | VE0011346 |
N/A | N-Nitroso Metformin | VE0010233 |
7068-83-9 | N-Nitroso Methyl Butyl Amine | VE006107 |
N/A | N-Nitroso Midodrine Impurity | VE0014312 |
N/A | N-Nitroso Migalastat | VE0014196 |
N/A | N-Nitroso Mirabegron | VE009905 |
N/A | N-Nitroso Mitoxantrone Impurity 1 | VE0014197 |
N/A | N-Nitroso Mitoxantrone Impurity 2 | VE0014199 |
1026879-47-9 | N-Nitroso Moexipril | VE0014201 |
N/A | N-Nitroso Morniflumate | VE0011306 |
N/A | N-Nitroso Moxifloxacin | VE008036 |
N/A | N-Nitroso N-BOC Piperazine Teneligliptin | VE007899 |
N/A | N-Nitroso N-Desbenzyl Nicardipine Impurity | VE0010197 |
N/A | N-Nitroso N-Desmethyl Citalopram | VE0013743 |
N/A | N-Nitroso N-Desmethyl Doxylamine | VE0014167 |
N/A | N-Nitroso N-Desmethyl Methadone | VE0014194 |
N/A | N-Nitroso N-Desmethyl Mifepristone | VE0014195 |
N/A | N-Nitroso N-Desmethyl Olanzapine Impurity | VE0010535 |
N/A | N-Nitroso N-desmethyl Nicardipine Impurity | VE0010196 |
N/A | N-Nitroso N-desmethyl Pheniramine | VE0014203 |
N/A | N-Nitroso Nadolol Impurity | VE0011254 |
2703749-87-3 | N-Nitroso Naphazoline | VE0011181 |
N/A | N-Nitroso Niflumic Acid | VE0011307 |
N/A | N-Nitroso Nilotinib | VE0011411 |
N/A | N-Nitroso Nimodipine | VE009628 |
N/A | N-Nitroso Nisoldipine | VE0014202 |
55855-42-0 | N-Nitroso Nortriptyline | VE008160 |
N/A | N-Nitroso O-Benzyl Indacaterol | VE0010554 |
N/A | N-Nitroso Olmesartan | VE0010543 |
N/A | N-Nitroso Olmesartan Medoxomil Impurity | VE007896 |
N/A | N-Nitroso Olodaterol | VE0014204 |
N/A | N-Nitroso Olopatadine N-Desmethyl Impurity | VE0010528 |
N/A | N-Nitroso Omeprazole | VE0010941 |
N/A | N-Nitroso Oxomemazine | VE0011308 |
N/A | N-Nitroso Ozanimod Impurity | VE009803 |
N/A | N-Nitroso Palbociclib | VE009744 |
N/A | N-Nitroso Pantoprazole | VE0010076 |
N/A | N-Nitroso Pazopanib | VE0011522 |
N/A | N-Nitroso Pemigatinib | VE0010447 |
N/A | N-Nitroso Perindopril | VE0011281 |
78658-64-7 | N-Nitroso Phenylephrine | VE0011182 |
N/A | N-Nitroso Pindolol | VE0014205 |
126209-21-0 | N-Nitroso Pirfenidone EP Impurity A | VE009705 |
2512237-43-1 | N-Nitroso Pirfenidone EP Impurity B | VE009706 |
N/A | N-Nitroso Plazomicin 1 | VE0014198 |
N/A | N-Nitroso Plazomicin 2 | VE0014200 |
94511-44-1 | N-Nitroso Promethazine Impurity | VE0011232 |
84418-35-9 | N-Nitroso Propranolol | VE007279 |
N/A | N-Nitroso Protriptyline | VE0014182 |
N/A | N-Nitroso Pyrantel Pamoate Impurity | VE008185 |
N/A | N-Nitroso Quinapril Impurity | VE0010651 |
N/A | N-Nitroso Quinoline Acid Impurity | VE0010065 |
N/A | N-Nitroso Rac N-Desmethyl Tramadol | VE0011408 |
N/A | N-Nitroso Ramipril | VE0010563 |
N/A | N-Nitroso Ranitidine-1 | VE0014169 |
N/A | N-Nitroso Ranolazine Impurity 1 | VE0010326 |
N/A | N-Nitroso Risdiplam | VE0014168 |
N/A | N-Nitroso Ritalinic | VE0012694 |
N/A | N-Nitroso Ropivacaine | VE0014753 |
2657645-00-4 | N-Nitroso Safinamide | VE0014161 |
N/A | N-Nitroso Salbutamol | VE009145 |
N/A | N-Nitroso Salmeterol | VE0013029 |
N/A | N-Nitroso Sildenafil | VE0011456 |
N/A | N-Nitroso Silodosin | VE007637 |
N/A | N-Nitroso Sitagliptin D4 | DVE00101 |
N/A | N-Nitroso Sitagliptin Impurity | VE009183 |
N/A | N-Nitroso TMB Impurity Olmesartan | VE007894 |
N/A | N-Nitroso Tamsulosin Impurity | VE0010482 |
N/A | N-Nitroso Teneligliptin | VE0010120 |
N/A | N-Nitroso Teneligliptin R-isomer | VE007900 |
N/A | N-Nitroso Terbutaline | VE009901 |
N/A | N-Nitroso Teriflunomide | VE0011282 |
N/A | N-Nitroso Tetracaine | VE0014146 |
N/A | N-Nitroso Theophylline | VE0011721 |
N/A | N-Nitroso Tigecycline | VE008528 |
N/A | N-Nitroso Timolol | VE0010214 |
N/A | N-Nitroso Tirofiban | VE0014143 |
N/A | N-Nitroso Tofacitinib | VE009521 |
N/A | N-Nitroso Tofacitinib Impurity 2 | VE0011615 |
N/A | N-Nitroso Torasemide EP Impurity B | VE0013145 |
N/A | N-Nitroso Trandolapril | VE0011528 |
N/A | N-Nitroso Trientine | VE0014142 |
N/A | N-Nitroso Urapidil Impurity | VE0010871 |
N/A | N-Nitroso Valsartan Impurity | VE008372 |
N/A | N-Nitroso Valsartan Methyl Ester Impurity | VE008373 |
N/A | N-Nitroso Valsartan-1 | VE0010124 |
N/A | N-Nitroso Verapamil Impurity-1 | VE0010164 |
N/A | N-Nitroso Vilanterol | VE0014141 |
N/A | N-Nitroso Vortioxetine | VE009743 |
N/A | N-Nitroso Zanubrutinib | VE009880 |
N/A | N-Nitroso Zidovudine | VE0014363 |
N/A | N-Nitroso amlodipine EP Impurity A | VE0010280 |
N/A | N-Nitroso dobutamine | VE007836 |
N/A | N-Nitroso isoproterenol | VE007833 |
86144-35-6 | N-Nitroso ketamine | VE0010448 |
N/A | N-Nitroso levofloxacin diamine | VE008449 |
N/A | N-Nitroso linezolid Impurity | VE0011947 |
N/A | N-Nitroso of Azithromycin Impurity I | VE007867 |
N/A | N-Nitroso of DSVRC-3 impurity Desvenlafaxin | VE007863 |
2680662-11-5 | N-Nitroso of Desvenlafaxin Impurity-A | VE007862 |
N/A | N-Nitroso of Leve Inter (LCTRC-3) Levetiracetam | VE007881 |
N/A | N-Nitroso of N-Demethyl erythromycin A (Azithromycin) | VE007865 |
N/A | N-Nitroso of ZTA-III Impurity (Azithromycin) | VE007866 |
2361294-43-9 | N-Nitroso paroxetine Impurity | VE0010300 |
55556-92-8 | N-Nitroso-1, 2, 3, 6-Tetrahydropyridine | VE009688 |
77400-46-5 | N-Nitroso-2, 2, 5-trimethyl-1, 3-oxazolidine | VE008028 |
N/A | N-Nitroso-3-Methyl Piperazine Impurity | VE008376 |
28698-93-3 | N-Nitroso-7-monomethylamino-6-deoxytetracycline | VE0011483 |
N/A | N-Nitroso-Acebutolol | VE007667 |
N/A | N-Nitroso-Acebutolol-D7 | DVE00106 |
N/A | N-Nitroso-Ambroxol | VE007666 |
N/A | N-Nitroso-Amoxapine | VE007665 |
N/A | N-Nitroso-Atomoxetine | VE007664 |
32635-81-7 | N-Nitroso-Betahistine | VE007663 |
N/A | N-Nitroso-Betaxolol | VE0012730 |
N/A | N-Nitroso-Bisoprolol | VE007662 |
864443-44-7 | N-Nitroso-Ciprofloxacin | VE007657 |
N/A | N-Nitroso-Desmethyl-Minocycline-1 | VE0014240 |
N/A | N-Nitroso-Desmethyl-Minocycline-2 | VE0014241 |
N/A | N-Nitroso-Desmethyl-Sildenafil | VE0011369 |
N/A | N-Nitroso-Desmethyl-Tetracycline | VE0014242 |
N/A | N-Nitroso-Drotaverine | VE007656 |
2680527-91-5 | N-Nitroso-Duloxetine | VE0010541 |
N/A | N-Nitroso-Felodipine | VE007653 |
30248-47-6 | N-Nitroso-L-azetidine-2-Carboxylic Acid | VE0010032 |
7519-36-0 | N-Nitroso-L-proline | VE007000 |
1152314-62-9 | N-Nitroso-Levofloxacin Impurity-1 | VE0010475 |
N/A | N-Nitroso-Lisinopril-D5 | DVE00515 |
N/A | N-Nitroso-Maprotiline | VE007643 |
62137-31-9 | N-Nitroso-Meglumine | VE009502 |
N/A | N-Nitroso-Moxonidine (mononitroso) | VE007642 |
2114-63-8 | N-Nitroso-N-2, 3-xylylanthranilic acid | VE006846 |
N/A | N-Nitroso-N-Desmethyl DEBA Zolmitriptan | VE007892 |
N/A | N-Nitroso-N-Desmethyl Zolmitriptan | VE007893 |
20689-96-7 | N-Nitroso-N-Ethyl-Benzylamine | VE006349 |
N/A | N-Nitroso-N-desmethyldoxycycline | VE0010971 |
4549-44-4 | N-Nitroso-N-ethylbutylamine | VE006113 |
614-00-6 | N-Nitroso-N-methyl N- phenylamine | VL3850093 |
61445-55-4 | N-Nitroso-N-methyl-4-aminobutyric Acid(NMBA) | VL3850049 |
1184996-41-5 | N-Nitroso-N-methyl-4-aminobutyric Acid-D3 | DVE0082 |
1821341-18-7 | N-Nitroso-N-methylaniline-d5 | DVE00217 |
937-40-6 | N-Nitroso-N-methylbenzylamine | VE006112 |
N/A | N-Nitroso-Pramipexole-D5 | DVE00102 |
N/A | N-Nitroso-Propafenone | VE007640 |
1850-88-0 | N-Nitroso-Pseudoephedrine | VE007671 |
N/A | N-Nitroso-Ranolazine | VE0010066 |
2470278-90-9 | N-Nitroso-Rasagiline (Mixture of Diastereomer) | VE007635 |
134720-07-3 | N-Nitroso-Sotalol | VE007638 |
52322-22-2 | N-Nitroso-Thambutol (Dinitroso) | VE007654 |
78213-39-5 | N-Nitroso-Thambutol (mononitroso) | VE007655 |
N/A | N-Nitroso-Trimetazidine (2 HCl) | VE007676 |
N/A | N-Nitroso-desmethyl Trimebutine | VE0011457 |
924-16-3 | N-Nitroso-di-n-butylamine(NDBA) | VL3850094 |
1219798-82-9 | N-Nitroso-di-n-butylamine-d18 | DVE007 |
29291-35-8 | N-Nitroso-folic acid | VE007631 |
N/A | N-Nitroso-furosemide | VE007632 |
N/A | N-Nitroso-hydroxychloroquine | VE007645 |
N/A | N-Nitroso-lacidipine | VE007644 |
N/A | N-Nitroso-pramipexole | VE007641 |
134720-04-0 | N-Nitrosoatenolol | VE007278 |
73785-40-7 | N-Nitrosocimetidine | VE008296 |
5336-53-8 | N-Nitrosodibenzylamine | VE006123 |
1116-54-7 | N-Nitrosodiethanolamine | VE006105 |
601-77-4 | N-Nitrosodiisopropylamine (NDIPA) | VL290023 |
N/A | N-Nitrosodimethylamine 13C-D6 | DVE0043 |
17829-05-9 | N-Nitrosodimethylamine-D6 | DVE0083 |
62-75-9 | N-Nitrosodimethylamine-¹³C₂D6 | DVE0099 |
86-30-6 | N-Nitrosodiphenylamine | VE006106 |
621-64-7 | N-Nitrosodipropylamine (NDPA) | VL3850098 |
69278-54-2 | N-Nitrosoethylmethylamine-d3 | DVE00218 |
25081-31-6 | N-Nitrosoiminodiacetic acid | VE007950 |
64768-29-2 | N-Nitrosomethylamine | VE0013228 |
26921-68-6 | N-Nitrosomethylethanolamine | VE006110 |
138768-62-4 | N-Nitrosometoprolol | VE007073 |
59-89-2 | N-Nitrosomorpholine | VL3850097 |
N/A | N-Nitrosonortriptyline-D3 | DVE0086 |
100-75-4 | N-Nitrosopiperidine | VL3850096 |
960049-21-2 | N-Nitrosopiperidine-D10 | DVE0081 |
930-55-2 | N-Nitrosopyrrolidine | VL3850099 |
N/A | N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2, 3-d]pyrimidin-4-amine | VE009895 |
30533-08-5 | N-methyl-N-nitroso-2-Propanamine | VL3850100 |
13256-11-6 | N-methyl-N-nitroso-Phenethylamine | VE006384 |
7417-67-6 | N-methyl-N-nitrosoacetamide | VE0011022 |
N/A | N-nitroso (3, 4-dimethylphenyl) hydrazine | VE0010337 |
N/A | N-nitroso 3, 5-Ivacaftor | VE0011349 |
55557-03-4 | N-nitroso Methylphenidate | VE009887 |
N/A | N-nitroso Verapamil Impurity F | VE0010324 |
N/A | N-nitroso amlodipine BP Impurity 1 | VE0010277 |
N/A | N-nitroso azithromycin EP impurity A | VE0010111 |
N/A | N-nitroso azithromycin EP impurity M | VE0010110 |
N/A | N-nitroso of GAT-II | VE008154 |
N/A | N-nitroso of Gatifloxacin | VE008153 |
N/A | N-nitroso tetrahydrofuroylpiprazine | VE009556 |
N/A | N-nitroso-N-desmethylnintedanib | VE009403 |
N/A | N-nitroso-Triazolopyrazine | VE009511 |
62-75-9 | N-nitroso-dimethylamine (NDMA) | VL3850010 |
N/A | N-nitrosonintedanib | VE009400 |
73870-33-4 | N-nitrosothiazolidine | VE007979 |
26360-21-4 | N10-Nitroso Folic Acid | VE008029 |
N/A | N2-Nitroso Articaine | VE0013877 |
N/A | N3-(1-nitrosopiperidin-4-yl)pyridine-2, 3-diamine | VE0010248 |
N/A | Naloxone Nitroso EP Impurity A | VE0011507 |
N/A | Nicardipine Nitroso Impurity | VE009915 |
N/A | Nintedanib Nitroso Impurity 1 | VE009401 |
N/A | Nitroso 4-HBS Impurity | VE007746 |
N/A | Nitroso 4-Hydroxycarbazole Impurity | VE007931 |
N/A | Nitroso Abacavir Impurity | VE006520 |
N/A | Nitroso Adenine | VE007649 |
N/A | Nitroso Amlodipine Impurity | VE007675 |
N/A | Nitroso Amlodipine Impurity B | VE007650 |
885-11-0 | Nitroso Antipyrine | VL6710004 |
N/A | Nitroso BCFI Impurity | VE007670 |
N/A | Nitroso Carvedilol EP Impurity D | VE007932 |
N/A | Nitroso Carvedilol Impurity | VE007933 |
N/A | Nitroso Cyanodiol Impurity | VE007930 |
N/A | Nitroso Derivative of Prucalopride Impurity A | VE0010531 |
N/A | Nitroso Dexchlorpheniramine Maleate | VE0011722 |
N/A | Nitroso Escitalopram EP Impurity A | VE007928 |
N/A | Nitroso Escitalopram EP Impurity C | VE007929 |
N/A | Nitroso Escitalopram ESTRC-1 | VE007926 |
N/A | Nitroso Escitalopram ESTRC-2 | VE007927 |
N/A | Nitroso Fluoro PBI Impurity | VE007755 |
N/A | Nitroso HPED [Nitroso hydroxy propylethyl diamine] | VE008152 |
6238-69-3 | Nitroso Isonipicotic Acid | VE007756 |
N/A | Nitroso Lansoprazole Sulfide Impurity | VE007974 |
N/A | Nitroso Losartan | VE006470 |
N/A | Nitroso Mercapto Impurity | VE007732 |
N/A | Nitroso Phthaloyl amlodipine | VE007651 |
N/A | Nitroso Piperazine Acetamide | VE007754 |
N/A | Nitroso Quinoline ester Gatifloxacin | VE008162 |
N/A | Nitroso Rabeprazole Impurity | VE007734 |
N/A | Nitroso Rabeprazole Sulfide | VE007733 |
N/A | Nitroso Rifabutin | VE009846 |
N/A | Nitroso VAL-II Impurity | VE007760 |
N/A | Nitroso Valsartan Benzyl Ester | VE007761 |
N/A | Nitroso aryl piperazine quetiapine | VE009553 |
67856-68-2 | Nitroso bis 2 chloro ethyl amine | VE006103 |
N/A | Nitroso-4-Hydroxy Carbazole | VE009482 |
N/A | Nitroso-DMPC Impurity | VE007762 |
N/A | Nitroso-Epoxy propoxy Carbazole | VE009483 |
N/A | Nitroso-Linalgiptin Dimer | VE0011982 |
N/A | Nitroso-pyrazolone | VE0010237 |
674-81-7 | Nitrosoguanidine | VE007849 |
924-46-9 | Nitrosomethylpropylamine | VE006122 |
42363-85-9 | Nitrous Hydrazide | VE0011364 |
N/A | Nizatidine Nitroso Impurity 1 | VE0010302 |
N/A | Nizatidine Nitroso Impurity 2 | VE0010303 |
N/A | Nizatidine Nitroso Impurity 3 | VE0010304 |
N/A | Olanzapine Nitroso Impurity 1 | VE0010251 |
N/A | Olanzapine Nitroso Impurity 3 | VE0010536 |
N/A | Olanzapine Nitroso Impurity 4 | VE0010252 |
N/A | Osimertinib Nitroso Impurity 2 | VE009896 |
N/A | Pantoprazole Nitroso Impurity 2 | VE0013066 |
356786-94-2 | Pantothenic Acid-13C3, 15N Hemicalcium Salt | VE0011072 |
N/A | Phenyl nitroso(2-(phenylthio)phenyl)carbamate | VE0012080 |
N/A | Plerixafor Nitroso Impurity 1 | VE0014187 |
N/A | Plerixafor Nitroso Impurity 2 | VE0014188 |
N/A | Plerixafor Nitroso Impurity 3 | VE0014189 |
N/A | Primaquine Nitroso Impurity | VE0011146 |
N/A | Propyl (2-amino-6-((4-fluorobenzyl)(nitroso)amino)pyridin-3-yl)carbamate - Flupirtine | VE007902 |
N/A | Rac-N-Nitroso Mirabegron | VE0010507 |
N/A | Ranitidine Nitroso Impurity 2 | VE0014181 |
N/A | Relugolix Nitroso Impurity 1 | VE009886 |
N/A | Ribociclib Nitroso Impurity 1 | VE0011446 |
N/A | Ribociclib Nitroso Impurity 2 | VE0010063 |
N/A | Ribociclib Nitroso Impurity 3 | VE0010064 |
N/A | Riociguat Nitroso Impurity C | VE0014343 |
N/A | Rivastigmine N-Nitroso Analog | VE0012222 |
N/A | Ruxolitinib Nitroso Impurity 1 | VE0011162 |
N/A | S, R, R-Thiomorpholine Derivative Nitroso Impurity | VE009979 |
N/A | S, S, S-Thiomorpholine derivative nitroso impurity | VE009978 |
N/A | S-MAA Nitroso Impurity | VE007669 |
N/A | Sapropterin Nitroso Impurity 1 | VE0014160 |
N/A | Sapropterin Nitroso Impurity 3 | VE008522 |
N/A | Sertraline Nitroso Impurity | VE007388 |
N/A | Sumatriptan Nitroso Impurity | VE0010178 |
N/A | Tert-butyl 4-((2-(ethyl(nitroso)amino)ethyl)carbamoyl)-3, 5-dimethyl-1H-pyrrole-2-carboxylate | VE0010009 |
N/A | Tert-butyl 4-((2-aminopyridin-3-yl)(nitroso)amino)piperidine-1-carboxylate | VE0010246 |
2476859-56-8 | Ticagrelor -3 Nitroso Impurity | VE008628 |
2476859-55-7 | Ticagrelor Nitroso Impurity | VE008489 |
N/A | Torasemide Nitroso Impurity 1 | VE009746 |
N/A | Valsartan Nitroso VAM-II | VE007988 |
N/A | Vancomycin Nitroso Impurity | VE0011293 |
N/A | Varenicline 7, 8-Dinitro-3-nitroso-2, 3, 4, 5-tetrahydro-1H-1, 5-methanobenzo[d]azepine | VE006887 |
N/A | Varenicline Nitrosamine Impurity | VE006440 |
79108-51-3 | Vildagliptin N-Nitroso-L-Prolinaminde | VE0010445 |
35909-01-4 | Vildagliptin N-Nitroso-L-Proline Methyl Ester | VE0010446 |
N/A | Zanubrutinib Nitroso Impurity 1 | VE009879 |
N/A | Ziprasidone EP Impurity A Nitroso | VE007390 |
N/A | methyl (Z)-3-(((4-(2-(4-methylpiperazin-1-yl)-N-nitrosoacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | VE009404 |
N/A | methyl 2-(2-chlorophenyl)-2-(nitroso(2-(thiophen-2-yl)ethyl)amino)acetate | VE009421 |
N/A | rac N-Nitroso-N-Desmethyl Dapoxetine | VE0011527 |
56859-26-8 | 1'-Nitrosobiotin | VE0010033 |
N/A | 1, 1'-(5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine-3, 7-diyl)diethanone | VE009783 |
N/A | 1, 2-dinitrosohydrazine | VE0011365 |
13980-04-6 | 1, 3, 5-trinitrosohexahydro-1, 3, 5- triazine | VE0011018 |
N/A | 1, 3-Dinitrosoguanidine | VE008761 |
N/A | 1, 7'-Dimethyl-3'-nitroso-2'- propyl-1H, 3'H-2, 5'- bibenzo[d]imidazole | VE0012689 |
N/A | 1-(2-((3-bromo-2, 4-dimethylphenyl)thio)phenyl)-4-nitrosopiperazine | VE0010503 |
N/A | 1-(2-chloropyrimidin-4-yl)-2-(3-(2, 6-difluorophenylsulfonamido)-2-fluorophenyl)-2-oxoethyl 2, 2-dimethylpropanimidothioate | VE0011062 |
N/A | 1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole | VE009494 |
N/A | 1-(4-((2, 4-dimethylphenyl)thio)phenyl)-4-nitrosopiperazine | VE0010504 |
N/A | 1-(4-bromo-5-(1-ethyl-7-(methyl(nitroso)amino)-2-oxo-1, 2-dihydro-1, 6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | VE009891 |
N/A | 1-(5-Nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepin-3-yl)ethan-1-one | VE009782 |
61379-64-4 | 1-Amino-4-cyclopentylpiperazine | VE006465 |
61379-66-6 | 1-Cyclopentyl-4-Nitrosopiperazine | VE006466 |
29643-62-7 | 1-Ethoxy-2-ethylbenzene | VE0011025 |
92432-50-3 | 1-Nitroso-4-(2, 3, 4-trimethoxy-benzyl)-piperazine | VE006792 |
7633-57-0 | 1-Nitrosoindoline | VE0012819 |
2819242-71-0 | 1-Nitrosopiperidin-3-amine | VE0011771 |
45590-75-8 | 1-Nitrosopyridinium | VE006351 |
N/A | 1-nitroso-1H-benzo[d]imidazole-2-thiol | VE0011546 |
N/A | 1-nitroso-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid | VE0011350 |
N/A | 10-chloro-7-nitroso-2, 7-dihydrodibenzo[b, f][1, 2]oxazeto[3, 4-d]azepine | VE009811 |
5424-21-5 | 2, 4-dichloro-6-methylpyrimidine | VE0011056 |
28177-48-2 | 2, 6-Difluorophenol | VE0011048 |
686258-75-3 | 2, 6-difluorobenzenesulfonic acid | VE0011049 |
N/A | 2-(3, 4-dimethylphenyl)-5-methyl-1-nitroso-1H-pyrazol-3(2H)-one | VE0010235 |
48121-20-6 | 2-(4-nitrosopiperazin-1-yl)ethanol | VE007038 |
N/A | 2-(7-ethyl-1-nitroso-1H-indol-3-yl)ethanol | VE0011264 |
13036-57-2 | 2-Chloro-4-methylpyrimidine | VE0011057 |
N/A | 2-Methyl-5-Nitro-1-Nitroso-1H-imidazole | VE006862 |
38361-37-4 | 2-chloro-1, 3-difluorobenzene | VE0011047 |
437-86-5 | 2-fluoro-1-methyl-3-nitrobenzene | VE0011045 |
317-46-4 | 2-fluoro-3-nitrobenzoic acid | VE0011044 |
N/A | 2-methyl-1-nitroso-1H-indole | VE0012824 |
41075-14-3 | 3, 7-Dichloro-5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine | VE009790 |
N/A | 3, 7-dinitro-5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine | VE009787 |
N/A | 3-(2, 6-difluoro-3, 5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-7-nitroso-3, 4-dihydro-1H-pyrrolo[3', 2':5, 6]pyrido[4, 3-d]pyrimidin-2(7H)-one | VE009883 |
N/A | 3-(2, 6-difluorophenylsulfonamido)-2-fluorobenzoic acid | VE0011060 |
N/A | 3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | VE009894 |
959007-11-5 | 3-Chloro-5-nitroso-5H-dibenzo[b, f]azepine | VE009799 |
N/A | 3-Methyl-1-nitrosopiperazine | VE008235 |
N/A | 3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-nitroso-3, 7-dihydro-1H-purine-2, 6-dione | VE0011768 |
N/A | 3-methyl-1-nitrosoindoline | VE0012823 |
N/A | 3-methyl-7-nitroso-3, 7-dihydro-1H-purine-2, 6-dione | VE0011770 |
N/A | 3-nitro-5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine | VE009786 |
N/A | 3-nitroso-2, 3, 4, 5-tetrahydro-1H-1, 5-methanobenzo[d]azepine | VE0010384 |
2219339-13-4 | 4-(3-Chlorophenyl)-1-nitrosopiperazine | VE0011239 |
3438-46-8 | 4-Methylpyrimidine | VE0011053 |
63779-86-2 | 4-Nitroso Hydrochlorothiazide | VE007633 |
N/A | 4-Nitroso hydrochlorothiazide-13C, 15N2, d2 | DVE004 |
N/A | 4-Nitrosopiperazin-1-amine | VE0013670 |
3435-25-4 | 4-chloro-6-methylpyrimidine | VE0011059 |
16219-99-1 | 4-nitrosomethylaminopyridine | VE006116 |
42579-28-2 | 42579-28-2: N-Nitroso Hydantoin | VE0014917 |
N/A | 5-({[1, 1'-biphenyl]-4-yl}methyl)-3-methyl-1-nitrosopyrrolidin-2-one | VE0010125 |
N/A | 5-Nitro-1-Nitroso-1H-imidazole | VE006863 |
N/A | 5-Nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepin-3-amine | VE009788 |
N/A | 5-[3-(4-Nitrosopiperazin-1-yl)propyl]-5H-dibenzo[b, f]azepine | VE0013976 |
N/A | 5-nitroso-10, 11-dihydro-5H-dibenzo[b, f]azepine-3, 7-diamine | VE009789 |
N/A | 6-fluoro-3-(4-piperidinyl)-1, 2-Benzisoxazole-nitrosamine | VE006599 |
2434-49-3 | 6-methyldihydropyrimidine-2, 4(1H, 3H)-dione | VE0011050 |
N/A | 7'-Methyl-1-nitroso-2'-propyl- 1H, 3'H-2, 5'- bibenzo(d)imidazole | VE0012691 |
N/A | 7-chloro-1-nitroso-2, 3, 4, 5-tetrahydro-1-benzazepin-5-ol | VE007639 |
N/A | 7-nitroso-7H-purine-6-thiol | VE006867 |
N/A | 8-bromo-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-nitroso-3, 7-dihydro-1H-purine-2, 6-dione | VE0011767 |
N/A | 8-bromo-3-methyl-7-nitroso-3, 7-dihydro-1H-purine-2, 6-dione | VE0011769 |
855931-91-8 | 855931-91-8: N-Nitroso-N-Phenyl-Glycine Anilide | VE0014815 |
N/A | ((1, 5-Dimethyl-3-oxo-2-phenyl-2, 3-dihydro-1H-pyrazol-4-yl)(nitroso)amino)methanesulfonic acid | VE0011347 |
N/A | (1-(2'-(1-Nitroso-1H-tetrazol-5-yl)-[1, 1'-biphenyl]-4-yl)-2-oxohexyl)-L-valine | VE009745 |
1038-06-8 | (1-nitrosopiperidin-4-yl)diphenylmethanol | VE007001 |
N/A | (2R)-2-((R)-1-(3, 5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine | VE009227 |
N/A | (2R, 3S)-2-((R)-1-(3, 5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-nitrosomorpholine | VE009228 |
N/A | (3R, 4R)-1-Nitroso Tofacitinib | VE009926 |
N/A | (4Z)-1-(3, 4-dimethylphenyl)-4-(hydroxyimino)-3-methyl-4, 5-dihydro-1H-pyrazol-5-one | VE0010236 |
N/A | (4bS, 8aS, 9S)-3-methoxy-11-nitroso-6, 7, 8, 8a, 9, 10-hexahydro-5H-9, 4b-(epiminoethano)phenanthrene | VE009881 |
5438-83-5 | (Nitrosoimino)bisacetic Acid Diethyl Ester | VE009192 |
N/A | (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-N-nitrosoacetamide | VE0010509 |
N/A | (R)-2-hydroxy-N-(4-nitrophenethyl)-N-nitroso-2-phenylacetamide | VE0010508 |
N/A | (R)-7-chloro-1-nitroso-2, 3, 4, 5-tetrahydro-1H-benzo[b]azepin-5-ol | VE009900 |
N/A | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-nitroso-3, 7-dihydro-1H-purine-2, 6-dione | VE0011766 |
N/A | (Z)-N-(2-(ethyl(nitroso)amino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2, 4-dimethyl-1H-pyrrole-3-carboxamide | VE0010012 |
FAQs:
The US Food and Drug Administration (FDA) released the final guidance document on the “Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs)”.
Nitrosamine guidance introduced a three-step process that manufacturers and applicants should take to mitigate nitrosamine impurities in their drug products. 1) Conduct risk assessments for nitrosamine impurities in their APIs and drug products, 2) Conduct confirmatory testing if risk is identified, 3) a report change is implemented to reduce or prevent the presence of nitrosamine impurities in drug products and APIs in approved and pending NDAs and ANDAs.
References:
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related
- https://www.fda.gov/media/170794/download
- FDA published the Nitrosamine Guidance on September 3, 2020 (85 FR 55017) https://www.fda.gov/regulatory-information/search-fda-guidance-documents.
- FDA Statement on FDA’s Ongoing Investigation Into Valsartan Impurities and Recalls and an Update on FDA’s Current Findings, available at https://www.fda.gov/news-events/press-announcements/fda-statement-fdasongoing-investigation-valsartan-impurities-and-recalls-and-update-fdas-current.